ARCHIVES

Second-Generation CML Drugs Show Promise For Frontline

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

SAIC Frederick Offers Use Of Drug Facility

August 4, 1995

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

ACS Says New Tax Policy Hurts Charity Funds

April 25, 1980

Cancer Screenings: American Over 50 Urged to Get Colon Caner Tests

March 5, 1999

In Brief: Robert Miller To Head International Affairs Office’ Pitot: No Basis for 20% Estimate

December 1, 1978

In Brief: House, Senate Authorization Measuring Waiting Floor Action; Money Bill Markups Pending

June 13, 1980